InterCure to Release its Q1 2022 Results and Hold a Conference Call
May 16 2022 - 12:30AM
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba
Canndoc)("InterCure" or the “Company”) today announced that it
plans to release financial results for the first quarter of 2022
after market close on Monday, May 16, 2022. The Company will
conduct a conference call on Tuesday, May 17, 2022, at 8:00a.m.
(Eastern Time) to review the results as well as provide an overview
of the Company’s recent milestones and growth strategy.
InterCure executives will host a live conference
call and audio webcast to discuss these results on Tuesday, May 17,
2022, at 8:00 am Eastern Time, details of which are provided
below.
To access the conference call, United States
participants please dial (844) 310-5056, or for international
callers, 1-706-679-4749. Conference ID: 6439945.
Participants can access the live webcast through
the following link:https://bit.ly/37MXcmN
A live webcast of the conference call can be
accessed on the ‘Events and Presentations’ section of the InterCure
website at http://www.intercure.co.
About InterCure (dba
Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX:
INCR.U) (TASE: INCR) is the leading, profitable, and fastest
growing cannabis company outside of North America. Canndoc, a
wholly owned subsidiary of InterCure, is Israel’s largest licensed
cannabis producer and one of the first to offer Good Manufacturing
Practices (GMP) certified and pharmaceutical-grade medical cannabis
products. InterCure leverages its market leading distribution
network, best in class international partnerships and a high-margin
vertically integrated "seed-to-sale" model to lead the fastest
growing cannabis global market outside of North America.
For more information, visit:
http://www.intercure.co.
Contact:
InterCure Ltd.Amos Cohen, Chief Financial
Officeramos@intercure.co
Intercure (TSX:INCR.U)
Historical Stock Chart
From Jun 2024 to Jul 2024
Intercure (TSX:INCR.U)
Historical Stock Chart
From Jul 2023 to Jul 2024